Study: Alzheimer’s Trials Are Basically Designed for White People
The majority of Alzheimer’s research to date has been conducted in white participants. For example, the first FDA-approved anti-amyloid drug to treat Alzheimer’s, Aduhelm,…
The majority of Alzheimer’s research to date has been conducted in white participants. For example, the first FDA-approved anti-amyloid drug to treat Alzheimer’s, Aduhelm,…
According to an Eisai press release, the U.S. Food and Drug Administration has now granted priority review to a new anti-amyloid drug by Biogen…
Dr. Tom Oxley has been obsessed with the brain since he was 13. “I studied medicine, because I just wanted to learn about the…
There were more than 140 experimental Alzheimer’s drugs in clinical trials as of the start of 2022. On the one hand, this number inspires…
Scientists have faced obstacle after obstacle in the search for effective Alzheimer’s drugs. While there are a number of symptomatic drugs approved by the…
A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…
Vaccines are considered one of the greatest innovations in medical history. Immunizations help train the body’s immune system to recognize and respond to a…
This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
UPDATE: 3 March 2024, 8:37 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
The busy life of brain cells is not so different from the supply chain that supports online purchases. A transaction is registered at a…
The brain’s power generators, mitochondria, could hold the key to Alzheimer’s. Despite accounting for just two percent of our body weight, the brain consumes…
Could the bacteria that causes gum disease also trigger Alzheimer’s? A drug candidate targeting this bacteria recently failed its early trials, but some experts…
Here’s how VOA’s 5 founders — including reporter Phil Gutis — responded to recent Aduhelm Medicare announcement. A few months ago, I received an…
UPDATE: 3 March 2024, 8:35 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Vaccines are one of the greatest medical advances in history. This strategy is now being applied to the treatment and prevention of Alzheimer’s. We…